Heme Synthesis and Porphyrias

Vocabulary practice flashcards covering the biochemical pathway of heme synthesis, regulation of hepatic vs. erythroid ALA synthase isoforms, porphyrias (AIP, PCT, CEP), and lead poisoning pathophysiology.

Heme

A planar coordination complex composed of ferrous iron ($Fe^{2+}$) and protoporphyrin IX that acts as an essential prosthetic group for oxygen-carrying proteins (hemoglobin, myoglobin) and functional enzymes (cytochrome c, cytochrome P450, catalase, and tryptophan pyrrolase).

ALAS1 (Hepatic Isoform)

The ubiquitous and hepatic isoform of $\delta$-aminolevulinic acid synthase that catalyzes the rate-limiting step of heme biosynthesis; it is induced by drugs such as barbiturates that increase cytochrome P450 synthesis, and down-regulated by hemin, heme, and glucose.

ALAS2 (Erythrocytic Isoform)

The erythroid-specific isoform of $\delta$-aminolevulinic acid synthase encoded on the X chromosome and expressed only in fetal liver and adult bone marrow; regulated by iron availability and erythropoietin, and coordinated with globin chain translation.

X-Linked Protoporphyria

A cutaneous disorder caused by a gain-of-function mutation in the $ALAS2$ gene on the X chromosome, producing excess porphyrin intermediates that overwhelm ferrochelatase and cause protoporphyrin IX accumulation, leading to reactive oxygen species generation and painful photosensitivity.

X-Linked Sideroblastic Anemia

A microcytic, hypochromic anemia caused by a loss-of-function mutation in the $ALAS2$ gene, resulting in impaired protoporphyrin and heme formation, leading to trapped non-heme iron within erythroid progenitor mitochondria and systemic iron overload.

Ringed Sideroblast

An abnormal erythroblast identified on iron (Prussian blue) stain containing five or more iron granules encircling more than one-third ($> 1/3$) of the nucleus, characteristic of sideroblastic anemia.

ALA Dehydratase

A zinc-dependent cytosolic enzyme that catalyzes the condensation of two molecules of $\delta$-aminolevulinic acid (ALA) to generate porphobilinogen (PBG); it is a primary enzyme target inhibited by lead.

Porphobilinogen Deaminase

A cytosolic enzyme (also known as hydroxymethylbilane synthase) that links four molecules of porphobilinogen into linear hydroxymethylbilane; its deficiency causes the autosomal dominant disease acute intermittent porphyria.

Acute Intermittent Porphyria (AIP)

An autosomal dominant acute hepatic porphyria caused by a deficiency in porphobilinogen deaminase (HMB synthase), marked by toxic accumulation of ALA and PBG, severe episodic abdominal and neuropsychiatric symptoms, and an absence of photosensitivity.

The 5 P's of AIP

A clinical mnemonic describing the major manifestations of acute intermittent porphyria: Painful abdomen, Polyneuropathy, Psychologic disturbances, Port wine-colored pee, and Precipitated by triggers like drugs.

Porphobilin Formation (AIP Urine Color Change)

The diagnostic transformation of normal or pale urine to a red-purple or port-wine color following $24\,\text{hours}$ of exposure to air and light, caused by the non-enzymatic spontaneous oxidation of accumulated porphobilinogen into dark porphobilin.

Porphyria Cutanea Tarda (PCT)

The most common porphyria, caused by deficient uroporphyrinogen decarboxylase activity; presents with uroporphyrin III accumulation in tissues and urine, fragile blistered skin, hyperpigmentation, hypertrichosis, and red-brown (tea-colored) urine upon sunlight exposure.

Congenital Erythropoietic Porphyria (CEP)

A rare autosomal recessive erythroid porphyria caused by deficiency in uroporphyrinogen III cosynthase (synthase), characterized by severe childhood-onset photosensitivity, ulcerative mutilating scarring, hemolytic anemia, red-stained teeth (erythrodontia), and severe hypertrichosis.

Ferrochelatase

The terminal mitochondrial enzyme of the heme pathway that coordinates ferrous iron ($Fe^{2+}$) into protoporphyrin IX to complete heme synthesis; it is deficient in erythropoietic protoporphyria and inhibited by lead.

Lead Poisoning (Plumbism)

Heavy metal toxicity resulting in impaired heme biosynthesis via the simultaneous inhibition of ALA dehydratase and ferrochelatase, causing accumulation of ALA, coproporphyrin III, and free erythrocyte protoporphyrin (FEP).

Burton's Lines

Bluish-purple or hyperpigmented lead lines seen along the gingival margin at the base of the teeth, representing a classic physical finding in chronic lead poisoning.

Basophilic Stippling

The appearance of coarse, blue-staining punctate ribosomal RNA aggregates within red blood cells on peripheral blood smear, caused by lead-induced inhibition of pyrimidine 5'-nucleotidase and rRNA degradation.

Hemin Therapy

An intravenous formulation of oxidized iron-protoporphyrin that aborts acute porphyria attacks by repressing transcription, decreasing mRNA stability, and blocking the mitochondrial import of ALAS1.

Glucose Loading

A treatment modality for acute porphyric attacks that inhibits peroxisome proliferator-activated receptor-gamma coactivator 1-alpha ($\text{PPAR-}\gamma$), down-regulating the transcription of ALAS1 and decreasing intermediate accumulation.

Isoniazid-Induced Sideroblastic Anemia

A secondary microcytic hypochromic anemia caused by competitive antagonism and depletion of pyridoxine (vitamin $B_6$), an obligatory cofactor for the rate-limiting ALA synthase reaction.

Subcellular Compartmentation of Heme Synthesis

The dual-compartment spatial organization of heme synthesis wherein the initial condensation reaction and the final three enzymatic steps occur inside the mitochondrion, while the middle four reactions take place in the cytosol.

Biochemical Basis of Porphyric Photosensitivity

A cutaneous pathology occurring in porphyrias involving enzymatic defects downstream of porphobilinogen deaminase, where accumulated porphyrinogens deposit in the skin, oxidize to porphyrins, and generate reactive oxygen species upon sunlight exposure.